50 research outputs found

    (The) research for the application status of basic CPR and AED by the hospital nurse

    No full text
    ์‘๊ธ‰๊ฐ„ํ˜ธ์ „๊ณต/์„์‚ฌ[ํ•œ๊ธ€]๋ณธ ์—ฐ๊ตฌ๋Š” ๊ธฐ๋ณธ ์‹ฌํ์†Œ์ƒ์ˆ  ๊ต์œก์„ ๋ฐ›์€ ๊ฐ„ํ˜ธ์‚ฌ๋ฅผ ๋Œ€์ƒ์œผ๋กœ ๊ธฐ๋ณธ ์‹ฌํ์†Œ์ƒ์ˆ ๊ณผ ์ œ์„ธ๋™๊ธฐ ๊ต์œก ๋ฐ ํ™œ์šฉ ํ˜„ํ™ฉ์„ ํŒŒ์•…ํ•œ ์กฐ์‚ฌ์—ฐ๊ตฌ์ด๋‹ค.์—ฐ๊ตฌ๋Œ€์ƒ์€ 700๋ณ‘์ƒ ์ด์ƒ์˜ ๋Œ€ํ•™๋ณ‘์›์—์„œ ๊ธฐ๋ณธ ์‹ฌํ์†Œ์ƒ์ˆ ์„ ๋ฐ›์€ ๊ฐ„ํ˜ธ์‚ฌ 400๋ช…์ค‘ ์—ฐ๊ตฌ์˜ ์ฐธ์—ฌ์— ๋™์˜ํ•œ 172๋ช…์„ ๋Œ€์ƒ์œผ๋กœ ์„ค๋ฌธ์กฐ์‚ฌํ•˜์—ฌ ๊ฒฐ๊ณผ๋ถ„์„์— ์‚ฌ์šฉ๋œ ์„ค๋ฌธ์ง€๋Š” 152๋ถ€ ์ด์—ˆ๋‹ค.์—ฐ๊ตฌ๋„๊ตฌ๋Š” ๋ณธ ์—ฐ๊ตฌ์ž์— ์˜ํ•ด ๊ฐœ๋ฐœ๋œ 37๋ฌธํ•ญ์˜ ์„ค๋ฌธ์ง€๋ฅผ ์‚ฌ์šฉํ•˜์˜€๋‹ค. BLS ๊ต์œกํ˜„ํ™ฉ, AED ๊ต์œกํ˜„ํ™ฉ, AED ๊ต์œกํ˜„ํ™ฉ, PAD์™€ AED ํ™œ์šฉ ํ˜„ํ™ฉ์— ๋Œ€ํ•ด์„œ ๋นˆ๋„์™€ ๋น„์œจ์„ ์‚ฐ์ถœํ•˜์˜€๋‹ค.๋ณธ ์—ฐ๊ตฌ์˜ ๊ฒฐ๊ณผ๋ฅผ ์ œ์‹œํ•˜๋ฉด ๋‹ค์Œ๊ณผ ๊ฐ™์•˜๋‹ค.1. ๋Œ€์ƒ์ž์˜ 70%๊ฐ€ 72๊ฐœ์›” ์ดํ•˜์˜ ๊ฒฝ๋ ฅ์„ ๊ฐ€์ง€๊ณ  ์žˆ์œผ๋ฉฐ ์•ฝ 85%๊ฐ€ ์ค‘ํ™˜์ž์‹ค ๊ณผ ์‘๊ธ‰์‹ค์— ๊ทผ๋ฌดํ•˜๊ณ  ์žˆ์—ˆ๋‹ค. ํ˜„ ๊ทผ๋ฌด ๋ณ‘์›์— CPR ์ „๋‹ดํŒ€์ด ์—†๋Š” ๊ฒฝ์šฐ๊ฐ€ 80.3% ์ด์—ˆ๋‹ค.2. BLS ๊ต์œก์€ ๋ณ‘์› ๋‚ด ์ž์ฒด ํ”„๋กœ๊ทธ๋žจ์„ ํ†ตํ•˜์—ฌ ๊ต์œก์ด ์ˆ˜ํ–‰๋˜๊ณ  ์žˆ๋Š” ๊ฒฝ์šฐ๊ฐ€ 67.8%์ด์—ˆ๊ณ  ์Šค์Šค๋กœ์˜ ํ•„์š”์„ฑ์— ์˜ํ•œ ์ž์ง„ ๊ต์œก๊ณผ ๋ณด์ˆ˜๊ต์œก ์ฐจ์›์— ์˜ํ•œ ๊ต์œก์ด ์ˆ˜ํ–‰๋˜๊ณ  ์žˆ๋Š” ๊ฒฝ์šฐ๊ฐ€ 50% ์ด์—ˆ์œผ๋ฉฐ, ๊ต์œก ๋นˆ๋„๋Š” 1๋…„์— 1ํšŒ ๊ต์œก ์„ ์‹ค์‹œํ•˜๋Š” ๊ฒฝ์šฐ๊ฐ€ 43.4๋กœ ๊ฐ€์žฅ ๋งŽ์•˜๋‹ค.3. BLS์˜ ๊ต์œก์ค‘์š”์„ฑ์— ๋Œ€ํ•ด์„œ๋Š” 10์  ๋งŒ์ ์— 8์  ์ด์ƒ์ด 76.9%์ด์—ˆ์œผ๋‚˜, BLS์˜ ์ž„์ƒ๊ณตํ—Œ๋„๋Š” 10์  ๋งŒ์ ์— 8์  ์ด์ƒ์ด 47.8% ์ด์—ˆ๋‹ค.4. ์—ฐ๊ตฌ๋Œ€์ƒ์ž์˜ ์•ฝ 80%๊ฐ€ AED ์ž‘๋™๊ต์œก์„ ๋ฐ›์•˜๊ณ  ์•ฝ 62%์˜ ๋Œ€์ƒ์ž๊ฐ€ AED ์ž‘๋™ ๋Šฅ๋ ฅ์ด ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค.5. ์—ฐ๊ตฌ๋Œ€์ƒ์ž์˜ 87.5%๊ฐ€ ์ œ์„ธ๋™๊ธฐ๋ฅผ ํ™•๋ณดํ•˜๊ณ  ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์œผ๋‚˜ ์ œ์„ธ๋™๊ธฐ ์ ์šฉ ์—ฌ๋ถ€๋Š” 61.8%๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ œ์„ธ๋™๊ธฐ ์ ์šฉ ์‹œ EKG ๋ฆฌ๋“ฌ์€ ASYTOLE๊ณผ VF/VT์ด 61.9%๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋˜ํ•œ ์‹ฌ์ •์ง€ ํ™˜์ž์—๊ฒŒ ์ œ์„ธ๋™๊ธฐ๋ฅผ ํ†ตํ•ด ์ง์ ‘ โ€œ์‡ฝโ€์„ ์ ์šฉํ•œ ๊ฒฝํ—˜์€ 16.4%๋กœ ์•„์ฃผ ๋‚ฎ์€ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค.6. AEDํ™œ์šฉ๋ฐฉ์•ˆ์— ๋Œ€ํ•ด์„œ๋Š” ์‹ฌ์ •์ง€ ํ™˜์ž์˜ ์˜์‹ ํ™•์ธ ํ›„ ์—ฐ๋ฝ๊ณผ AED ์‚ฌ์šฉ์ด 50.7%๋กœ ๊ฐ€์žฅ ๋งŽ์•˜๊ณ  ์‹ฌ์ •์ง€ ํ™˜์ž ์˜์‹ ํ™•์ธ ํ›„ ๊ตฌ์กฐ์š”์ฒญ ์‹œ AED๋ฅผ ์„ ํƒํ•œ ์ด์œ ๋Š” ๋ฆฌ๋“ฌ ํ™•์ธ์˜ ์ฑ…์ž„์ด ์—†๊ณ  ์‚ฌ์šฉ ๋ฐฉ๋ฒ•์ด ๊ฐ„๋‹จํ•œ ๊ฒƒ์ด ์ฃผ๋œ ์ด์œ ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. AED ์‚ฌ์šฉ์ž๋Š” ์ผ๋ฐ˜์ธ๋ณด๋‹ค ์˜๋ฃŒ์ธ์—๊ฒŒ ์‚ฌ์šฉ ๊ถŒํ•œ์„ ์ฃผ์–ด์•ผ ํ•œ๋‹ค๋Š” ์˜๊ฒฌ์ด ๋” ๋†’์€ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค.๊ฒฐ๋ก ์ ์œผ๋กœ ๋ณ‘์› ๊ฐ„ํ˜ธ์‚ฌ์˜ ๊ธฐ๋ณธ ์‹ฌํ์†Œ์ƒ์ˆ ์— ๋Œ€ํ•œ ๊ต์œก์€ ๋ณ‘์› ๋‚ด ์ž์ฒด ํ”„๋กœ๊ทธ๋žจ์œผ๋กœ ์ง„ํ–‰๋˜๊ณ  ์žˆ์œผ๋ฉฐ ์Šค์Šค๋กœ์˜ ํ•„์š”์„ฑ๊ณผ ๋ณด์ˆ˜๊ต์œก ์ฐจ์›์—์„œ ๊ต์œก์— ์ฐธ์—ฌํ•˜๊ณ  ์žˆ์—ˆ๋‹ค. ๋˜ํ•œ ๊ฐ„ํ˜ธ์‚ฌ์˜ ๋Œ€๋ถ€๋ถ„์ด ๊ธฐ๋ณธ ์‹ฌํ์†Œ์ƒ์ˆ ์˜ ๊ต์œก์ด ์ค‘์š”ํ•˜๋‹ค๊ณ  ์ธ์ง€ํ•˜๊ณ  ์žˆ์œผ๋‚˜ ์ž„์ƒ๊ณตํ—Œ๋„๋Š” ๋‚ฎ์€ ๊ฒƒ์œผ๋กœ ์ธ์ง€ํ•˜๊ณ  ์žˆ์—ˆ๋‹ค. ๋˜ํ•œ ์‹ฌ์ •์ง€ ํ™˜์ž ์˜์‹ ํ™•์ธ ํ›„ ์—ฐ๋ฝ๊ณผ AED ์‚ฌ์šฉ์ด ํ•„์š”ํ•˜๋‹ค๊ณ  ์ธ์‹ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ AED๋Š” ์˜๋ฃŒ์ธ์ด ์‚ฌ์šฉํ•ด์•ผ ํ•œ๋‹ค๋Š” ์˜๊ฒฌ์ด ๋†’์•˜๋‹ค.๋”ฐ๋ผ์„œ EKG ๋ถ„์„์˜ ๋ถ€๋‹ด์ด ์—†์œผ๋ฉด์„œ ๋ชจ๋‹ˆํ„ฐ์™€ ์‹ฌ์‹ค์„ธ๋™๊ณผ ๊ฐ™์€ ์ค‘๋Œ€ ์งˆํ™˜์ธ ๊ฒฝ์šฐ ์‡ฝ ์น˜๋ฃŒ๋ฅผ ๋ฐ”๋กœ ์‹คํ–‰ํ•  ์ˆ˜ ์žˆ๋Š” AED๊ฐ€ ๋ณ‘์› ๋‚ด ๊ทธ๋ฆฌ๊ณ  ๊ฐ ๋ณ‘๋™ ๋‚ด์— ์„ค์น˜, ํ™œ์šฉ ๋  ์ˆ˜ ์žˆ๋Š” ๋ฐฉ๋ฒ•๊ณผ ์‹ค์ œ ํ™˜์ž๋ฐœ๊ฒฌ์˜ ์ผ์ฐจ์  ์˜๋ฃŒ์ธ์ธ ๊ฐ„ํ˜ธ์‚ฌ๋“ค์ด ์กฐ๊ธฐ์ œ์„ธ๋™์„ ์‹œํ–‰ํ•  ์ˆ˜ ์žˆ๋„๋ก ๋ฐฉ์•ˆ ๋ชจ์ƒ‰์ด ์ด๋ฃจ์–ด์ ธ์•ผ ํ•œ๋‹ค. [์˜๋ฌธ]This study is to research basic Cardiopulmonary Resuscitation(CPR) and the status of AED(Automatic External Defibrillator) education and utilization to a group of nurses who were educated basic CPR.The questionnaire was 152 copies about the target of 172 nurses who were attended to this study out of 400 nurses who were educated by basic CPR at university hospital of over 700 medical condition.A tool of this study used 37 questions of the questionnaires that were made by the researcher of this study.The frequency and the rate were produced about the status of BLS(Basic life Support) and AED education, the status of AED and PAD utilization.The following is the result of this study.1. 70% of nurses have career below 72 months and about 85% of them were working in Intensive Care Unit(ICU) and emergency room.The case which has no the team that takes full charge of CPR in current working hospital was 80.3%.2. About BLS education, it was 67.8% that was being carried out training through the educational program in own hospital and, about the education for the need in person and by filling up, it was 50%, and about the education frequency, it was 43.4% that the case that the education was being carried out 1 time in a year.3. 76.8% of them got over 8 points out of 10 about the importance of BLS education but, 47.8% of them got over 8 points out of 10 about the degree of clinic contribution of BLS.4. About 80% of nurses were educated by AED functioning education, and it was shown that about 62% of nurses had AED functioning ability.5. It was shown that about 87.5 % of nurses had AED, but it was 61.9% whether AED was applied or not.Also, it was shown that the experience that they applied for a shock to a cardiac arrest patient through AED directly was very low, it was 16.4%.6. It was strongest that contact after check up with the consciousness of a cardiac arrested patient and the use of AED for utilization plan of AED were 50.7%, and some of the reasons for selecting AED, the main reason was shown that it is not responsible for identification of rhythm and the method of use is simple.It was shown that the opinion that it has to be given the right of use to a paramedic than a public person about the use of AED.In conclusion, the education about basic CPR of a nurse in hospital is being carried out training through the program in own hospital and they were taking part in the education for the need in person and by filling up.Also, most of them recognized for the importance of the education of CPR, but most of them recognized that the degree of the clinic contribution was low.Besides, they were recognizing that the use of AED and contact after check up with the consciousness of a cardiac arrested patient are need and the opinion that a paramedic has to use AED was strongest.Therefore, with no burden for EKG(Electrocardiogram) analysis, in case of serious disease like Ventricular Fibrillation, it will have to be discussed that how to be made use of AED which is able to carry out shock medical cure immediately?and be installed a monitor within hospital and each ward, and it will try to look for ways for nurses who are the first paramedic of patient discovery in effect to carry out AED.ope

    Low temperature electrical conduction of insulating granular In/InOx films

    No full text
    Maste

    ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”์—์„œ HB-EGF์˜ ์–ต์ œํšจ๊ณผ

    No full text
    Dept. of Dental Science/๋ฐ•์‚ฌ[ํ•œ๊ธ€]๋น„๋งŒ์€ ์šฐ๋ฆฌ ๋ชธ์˜ ์ง€๋ฐฉ์กฐ์ง์ด ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”์— ์˜ํ•ด ๋น„์ •์ƒ์ ์œผ๋กœ ์ฆ๊ฐ€๋œ ์ƒํƒœ๋กœ ๋ถˆ๊ท ํ˜•์ ์ธ ์—๋„ˆ์ง€์˜ ๊ณผ์ž‰๊ณต๊ธ‰์œผ๋กœ ์œ ๋ฐœ๋œ๋‹ค. ๋น„๋งŒ์€ ๊ณ ํ˜ˆ์••, ๊ณ ์ง€์งˆ์ฆ, ๋™๋งฅ๊ฒฝํ™”, ์‹ฌ์žฅ์งˆํ™˜ ๋ฐ ์ธ์Š๋ฆฐ ๋น„์˜์กดํ˜• ์ œ2ํ˜• ๋‹น๋‡จ๋ณ‘๊ณผ ๊ฐ™์€ ์„ฑ์ธ์„ฑ ์งˆํ™˜์„ ์œ ๋„ํ•˜๋Š” ๊ฐ€์žฅ ์ค‘์š”ํ•œ ์œ„ํ—˜์ธ์ž๋กœ ์ž‘์šฉํ•˜๊ธฐ ๋•Œ๋ฌธ์— ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”์™€ ์ง€๋ฐฉ๋Œ€์‚ฌ ์กฐ์ ˆ์— ๋Œ€ํ•œ ๊ด€์‹ฌ์ด ๋”์šฑ ์ง‘์ค‘๋˜๊ณ  ์žˆ๋‹ค.์ง€๋ฐฉ์„ธํฌ๊ฐ€ ๋‹จ์ˆœํžˆ ์ˆ˜๋™์ ์ธ ์—๋„ˆ์ง€ ์ €์žฅ๊ณ ๋ผ๋Š” ๊ฐœ๋…์—์„œ ์—๋„ˆ์ง€ ๋Œ€์‚ฌ๋ฅผ ๋น„๋กฏํ•œ ์ฒด๋‚ด ์—๋„ˆ์ง€ ํ•ญ์ƒ์„ฑ์„ ์œ ์ง€์‹œ์ผœ์ฃผ๋Š” ๊ธฐ๋Šฅ์„ ์ˆ˜ํ–‰ํ•˜๋Š” ์กฐ์ง์œผ๋กœ ์ƒ๊ฐ๋˜๋ฉด์„œ ์ง€๋ฐฉ์„ธํฌ์˜ ๋‹ค์–‘ํ•œ ๊ธฐ๋Šฅ์— ๋Œ€ํ•œ ์—ฐ๊ตฌ๊ฐ€ ์ง„ํ–‰๋˜๊ณ  ์žˆ๋‹ค. ์ง€๋ฐฉ์„ธํฌ์—์„œ ์—ฌ๋Ÿฌ ๊ฐ€์ง€ cytokine, hormone, lipid ๋“ฑ์ด ๋ถ„๋น„๋˜๋Š”๋ฐ ์ด๋Ÿฌํ•œ ๋ฌผ์งˆ๋“ค์˜ ๋น„์ •์ƒ์ ์ธ ๋ถ„๋น„๊ฐ€ ๋น„๋งŒ๊ณผ ๋‹น๋‡จ์™€ ๊ฐ™์€ ์„ฑ์ธ์„ฑ ์งˆ๋ณ‘๋“ค์˜ ์›์ธ์œผ๋กœ ์ž‘์šฉํ•  ์ˆ˜ ์žˆ๋‹ค๊ณ  ๋ฐํ˜€์ง€๊ณ  ์žˆ๋‹ค. ์ง€๋ฐฉ์„ธํฌ์—์„œ ์ƒ์„ฑ๋˜๋ฉฐ ๋‹ค์–‘ํ•œ ์‹ ํ˜ธ ์ „๋‹ฌ์— ๊ด€์—ฌํ•˜๋Š” leptin, adiponectin, resistin, IL-6 ๋“ฑ์˜ ๋ฌผ์งˆ๋“ค์„ ํ†ต์นญํ•ด์„œ adipocytokine ์ด๋ผ๊ณ  ๋ช…๋ช…ํ•˜์˜€๊ณ , ์ตœ๊ทผ์—๋Š” HB-EGF ์—ญ์‹œ ์ง€๋ฐฉ์กฐ์ง์—์„œ ๋ฐœํ˜„ํ•˜๋Š”adipocytokine ์ค‘ ํ•˜๋‚˜๋กœ์„œ ๋น„๋งŒ์— ๊ด€๋ จ๋œ ์„ฑ์žฅ์ธ์ž๋กœ ์ƒˆ๋กญ๊ฒŒ ์ธ์‹๋˜๊ณ  ์žˆ๋‹ค.๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” adipocytokine์ค‘ ํ•˜๋‚˜์ธ HB-EGF๊ฐ€ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”์—์„œ ์–ด๋–ค ์—ญํ• ์„ ํ•˜๋Š”์ง€ ์•Œ์•„๋ณด์•˜๋‹ค. HB-EGF๋Š” ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™” ์œ ๋„ ์ค‘ ์ดˆ๊ธฐ๋‹จ๊ณ„์—์„œ๋Š” ๊ทธ ๋ฐœํ˜„์ด ์ค„์–ด ๋“ค์—ˆ๋‹ค๊ฐ€ ํ›„๊ธฐ๋‹จ๊ณ„์—์„œ ๋‹ค์‹œ ๋ฐœํ˜„ํ•˜๋Š” ์–‘์ƒ์„ ๋ณด์˜€๋‹ค. 3T3-L1, 3T3-F442A preadipocyte cell๊ณผ mesenchymal stem cell๊ณผ ์œ ์‚ฌํ•œ C3H10T1/2 cell์— HB-EGF๋ฅผ ์ฒ˜๋ฆฌํ•˜์—ฌ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”๋ฅผ ์œ ๋„ํ–ˆ์„ ๋•Œ, HB-EGF๋Š” ์ด๋Ÿฌํ•œ ์„ธํฌ์˜ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”๋ฅผ ์–ต์ œ์‹œ์ผฐ๊ณ , ํฅ๋ฏธ๋กญ๊ฒŒ๋„C3H10T1/2 cell์˜ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”์—์„œ ๊ฐ€์žฅ ํฐ ์–ต์ œํšจ๊ณผ๋ฅผ ๋ณด์˜€๋‹ค. Adipocyte marker gene์ธ aP2, PPARฮณ ๊ทธ๋ฆฌ๊ณ  C/EBPฮฑ์˜ ๋ฐœํ˜„๋„ ๊ฐ์†Œํ•˜์˜€๋‹ค. HB-EGF์˜ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™” ์–ต์ œํšจ๊ณผ ์‹œ๊ธฐ๋ฅผ ์•Œ์•„๋ณด๊ธฐ ์œ„ํ•ด ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”์˜ ๋‹ค์–‘ํ•œ ์‹œ๊ธฐ์— HB-EGF๋ฅผ ์ฒ˜๋ฆฌํ•ด ๋ณธ ๊ฒฐ๊ณผ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™” ์ดˆ๊ธฐ๋‹จ๊ณ„๊ฐ€ HB-EGF์˜ ์–ต์ œํšจ๊ณผ๋ฅผ ์œ„ํ•ด ์ค‘์š”ํ•œ ์‹œ๊ธฐ์ž„์„ ์•Œ์•˜๊ณ , ์ค‘๊ธฐ๋‚˜ ํ›„๊ธฐ ๋‹จ๊ณ„์—์„œ๋Š” HB-EGF์˜ ์–ต์ œํšจ๊ณผ๋ฅผ ๋ณผ ์ˆ˜ ์—†์—ˆ๋‹ค. ๋˜ํ•œHB-EGF๊ฐ€ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™” ์œ ๋„ ์ „๋‹จ๊ณ„์ธ commitment ๋‹จ๊ณ„์—์„œ๋„ ์–ต์ œํšจ๊ณผ๋ฅผ ๋ณด์ด๋Š”์ง€ ์•Œ์•„๋ณด๊ธฐ ์œ„ํ•ด HB-EGF๋ฅผ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”๋ฅผ ์œ ๋„ํ•˜๊ธฐ ์ „์— ์ฒ˜๋ฆฌํ•œ ๊ฒฐ๊ณผ ๋šœ๋ ทํ•œ ์–ต์ œํšจ๊ณผ๋ฅผ ๋ณด์˜€๋‹ค. Pluripotent stem cell์„ adipocyte lineage๋กœ์˜ commitment๋ฅผ ์œ ๋„ํ•œ๋‹ค๊ณ  ์•Œ๋ ค์ ธ ์žˆ๋Š” BMP4์™€ ํ•จ๊ป˜ ์ฒ˜๋ฆฌํ•˜์—ฌ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”๋ฅผ ์œ ๋„ํ–ˆ์„ ๋•Œ๋„ ์–ต์ œํšจ๊ณผ๋ฅผ ๋ณด์˜€๋‹ค. ์ด๋Ÿฌํ•œ ๊ฒฐ๊ณผ๋Š” HB-EGF๊ฐ€ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”์œ ๋„ ์ดˆ๊ธฐ๋‹จ๊ณ„์—์„œ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ adipocyte lineage commitment ๋‹จ๊ณ„์—์„œ๋„ ์–ต์ œํšจ๊ณผ๊ฐ€ ์žˆ์Œ์„ ์‹œ์‚ฌํ•œ๋‹ค.๋”ฐ๋ผ์„œHB-EGF๋Š” ์ดˆ๊ธฐ๋‹จ๊ณ„์—์„œ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™”๋ฅผ ์–ต์ œํ•˜๊ธฐ ๋•Œ๋ฌธ์— ์ง€๋ฐฉ์„ธํฌ๋กœ ๋ถ„ํ™”๋˜๋Š” ์ดˆ๊ธฐ๋‹จ๊ณ„ ์„ธํฌ์—์„œ๋Š” HB-EGF์˜ ๋ฐœํ˜„์ด ์ค„์–ด๋“ค๊ณ , ํ›„๊ธฐ๋‹จ๊ณ„์— ๋‹ค์‹œ ๋ฐœํ˜„ํ•˜๋Š” HB-EGF๋Š”pluripotent stem cell๊ณผ preadipocyte์˜ ์ง€๋ฐฉ์„ธํฌ๋ถ„ํ™” ์‹œ์ž‘์„ ์–ต์ œํ•จ์œผ๋กœ์จpluripotent stem cell์˜ potential์„ ์œ ์ง€์‹œ์ผœ ์ฃผ๋ฉฐ ์ด๋กœ์จ ๋น„๋งŒํ˜•์„ฑ์„ ์กฐ์ ˆํ•˜๋Š” ์—ญํ• ์„ ํ•  ๊ฒƒ์ด๋ผ๊ณ  ์ถ”์ •ํ•œ๋‹ค. [์˜๋ฌธ]Obesity poses a serious health risk contributing to the increased prevalence of a host of other diseases including type 2 diabetes, hyperlipidemia, hypercholesterolemia and hypertension. Adipose tissue is vital for maintaining whole body energy homeostasis. It has traditionally been considered a mere energy depot, synthesizing and storing triglycerides during periods of caloric excess and releasing free fatty acids and glycerol during periods of nutritional deprivation. However, it is now recognized to play a more active role in regulating glucose and lipid metabolism as an endocrine organ secreting biologically active molecules (leptin, adiponectin, resistin, IL-6, etc.), so called adipocytokines. Adipocytokines are associated with adipocyte differentiation and metabolic disorders. Recently, Heparin-binding EGF-like growth factor (HB-EGF) was identified as an adipocytokine expressed in adipose tissue.In order to elucidate the biological characteristics of adipose tissue, this study investigated the effect of HB-EGF on adipocyte differentiation of 3T3-L1 and 3T3-F442A preadipocyte cells, and mecenchymal stem cell –like C3H10T1/2 (10T1/2) cells. HB-EGF decreased intracellular lipid accumulation in 3T3-L1, 3T3-F442A and 10T1/2 cells and significantly reduced expression of most adipocyte marker genes including aP2, PPARฮณ and C/EBPฮฑ, suggesting that HB-EGF inhibits adipogenesis. Upon adipogenic conversion, HB-EGF displayed dynamic changes in expression where an initial decrease was followed by increased levels of expression at later stages. Administration of HB-EGF for various periods during adipocyte differentiation revealed an inhibitory effect on adipocyte differentiation at the early induction stage but no effect at later stages. In addition, HB-EGF showed an inhibitory effect at the commitment stage in 10T1/2 cells, when pluripotent stem cells can be induced to commit to the adipocyte lineage prior to the induction, and even at the bone morphogenic protein (BMP) 4-triggering commitment stage. These data suggest that HB-EGF has inhibitory effects on commitment as well as the early induction stages. Due to the inhibitory effects of HB-EGF on the adipocyte differentiation, 3T3-L1, 3T3-F442A and 10T1/2 cells may halt the endogenous expression of HB-EGF at the early stage and the endogenous expression of HB-EGF at the late stage may negatively regulate initiation of the other adipocyte differentiation for the feedback.prohibitio

    ์ค‘ํ•™๊ต ํ™”ํ•™์— ์ ์šฉํ•œ ํ•ด๊ฒฐ์žยท์ฒญ์ทจ์ž ํ™œ๋™์—์„œ ์˜์‚ฌ์†Œํ†ต ๋ถˆ์•ˆ ์ˆ˜์ค€์— ๋”ฐ๋ฅธ ์†Œ์ง‘๋‹จ ๊ตฌ์„ฑ์˜ ํšจ๊ณผ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ) --์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ณผํ•™๊ต์œก๊ณผ(ํ™”ํ•™์ „๊ณต),2008.2Maste

    Heparin-binding epidermal growth factor-like growth factor inhibits adipocyte differentiation at commitment and early induction stages.

    No full text
    Adipocytokines, bioactive molecules secreted from adipose tissues, play important roles in physiology, development, and disease. Recently, heparin-binding epidermal growth factor-like growth factor (HB-EGF) was identified as an adipocytokine whose expression correlates with obesity. However, the biological role of fat-secreted HB-EGF is still unclear. In this study, we investigated the effects of HB-EGF on the adipocyte differentiation of C3H10T1/2 pluripotent mesenchymal cells. Upon adipogenic conversion of C3H10T1/2 cells, HB-EGF displayed dynamic changes in expression where an initial decrease was followed by increased levels of expression at later stages. HB-EGF treatment during adipogenic induction inhibited lipid accumulation and decreased the expression of adipocyte molecular markers (fatty acid-binding protein, peroxisome proliferator-activated receptor gamma, and CAAT enhancer-binding protein alpha) and lipogenic genes (glucose transporter, fatty acid synthetase, and lipoprotein lipase). Therefore, HB-EGF has an inhibitory effect on adipocyte differentiation. Administration of HB-EGF at various intervals during adipocyte differentiation revealed that HB-EGF acts during the early stages of adipocyte differentiation, but not at the later stages of differentiation. Furthermore, HB-EGF was able to block the commitment of pluripotent mesenchymal cells to the adipocyte lineage triggered by bone morphogenic protein 4 treatment. These data suggest that HB-EGF acts as a negative regulator of adipogenesis by inhibiting the commitment and early differentiation of the adipose lineage. The inhibitory role of HB-EGF on adipocyte differentiation of pluripotent mesenchymal cells sheds light on potential mechanisms that control adipose tissue homeostasis.ope

    The Tendency Analysis of Korean Traditional Textile Studies

    No full text

    Effects of heparin-binding epidermal growth factor-like growth factor on cell repopulation and signal transduction in periodontal ligament cells after scratch wounding in vitro

    No full text
    BACKGROUND AND OBJECTIVE: A growing amount of attention has been placed on periodontal regeneration and wound healing for periodontal therapy. This study was conducted in an effort to determine the effects of heparin-binding epidermal growth factor-like growth factor on cell repopulation and signal transduction in periodontal ligament cells after scratch wounding in vitro. MATERIAL AND METHODS: Human periodontal ligament cells were acquired from explant tissue of human healthy periodontal ligament. After the wounding of periodontal ligament cells, the change in expression of heparin-binding epidermal growth factor-like growth factor and epidermal growth factor receptors 1-4 mRNA was assessed. The effects of heparin-binding epidermal growth factor-like growth factor on periodontal ligament cell proliferation and repopulation were assessed in vitro via the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and by photographing the injuries, respectively. Extracellular signal-regulated kinase (Erk)1/2, p38 and Akt phosphorylation was characterized via western blotting. RESULTS: Scratch wounding resulted in a significant up-regulation of heparin-binding epidermal growth factor-like growth factor mRNA expression, whereas wounding had no effect on the expression levels of epidermal growth factor receptors 1-4. Interestingly, no expression of epidermal growth factor receptors 2 and 4 was detectable prior to or after wounding. Heparin-binding epidermal growth factor-like growth factor treatment promoted the proliferation and repopulation of periodontal ligament cells. The scratch wounding also stimulated the phosphorylation of Erk1/2 and p38, but not of Akt, in periodontal ligament cells, and heparin-binding epidermal growth factor-like growth factor treatment applied after wounding amplified and extended the activations of Erk1/2 and p38, but not of Akt. Furthermore, Erk1/2 inhibition blocked the process of cell repopulation induced by heparin-binding epidermal growth factor-like growth factor, whereas the inhibition of p38 delayed the process. CONCLUSION: These results indicate that heparin-binding epidermal growth factor-like growth factor may constitute a critical factor in the wound healing of human periodontal ligament cells by a mechanism that requires the activation of Erk1/2 via specific interaction with epidermal growth factor receptor 1.ope
    corecore